Randomized Phase III Study Comparing Paclitaxel–Bleomycin, Etoposide, and Cisplatin (BEP) to Standard BEP in Intermediate-Prognosis Germ-Cell Cancer: Intergroup Study EORTC 30983

PURPOSE: To compare the efficacy of four cycles of paclitaxel–bleomycin, etoposide, and cisplatin (T-BEP) to four cycles of bleomycin, etoposide, and cisplatin (BEP) in previously untreated patients with intermediate-prognosis germ-cell cancer (GCC). PATIENTS AND METHODS: Patients were randomly assi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: de Wit, Ronald, Skoneczna, Iwona, Daugaard, Gedske, De Santis, Maria, Garin, August, Aass, Nina, Witjes, Alfred J., Albers, Peter, White, Jeffery D., Germa-Lluch, José R., Marreaud, Sandrine, Collette, Laurence
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2012
Témata:
Original Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3295568/
https://ncbi.nlm.nih.gov/pubmed/22271474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.37.0171
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky